Since the potential actions of KYN metabolites on the glutamatergic system75,76 are thought to contribute to MDD risk, our results suggest that AHR may play a role in regulating KYN biosynthesis and, as a result, may contribute to MDD pathophysiology. The gene discussed is AHR; the disease is major depressive disorder.